Effects of a Partially Supervised Conditioning Program in CF



Status:Completed
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:12 - Any
Updated:10/24/2018
Start Date:July 1, 2014
End Date:October 15, 2018

Use our guide to learn which trials are right for you!

Effects of a Partially Supervised Conditioning Program in CF: an International Multi-centre, Randomized Controlled Trial

Physical activity and exercise have become an accepted and valued component of Cystic
Fibrosis care. Regular physical activity and exercise can slow the rate of decline of
pulmonary function, improve physical fitness, and enhance quality of life. However,
motivating people to be more active is challenging. Supervised exercise programs are
expensive and labor intensive, and adherence falls off significantly once supervision ends.
Unsupervised or partially supervised programs are less costly and more flexible, but
compliance can be more problematic. The primary objective of this study is to evaluate the
effects of a 12-months partially supervised exercise intervention along with regular
motivation on forced expiratory volume in 1 second (FEV1) in a large international group of
cystic fibrosis patients. Secondary endpoints include patient reported quality of life, as
well as levels of anxiety and depression, and control of blood sugar. A total of 292 patients
with cystic fibrosis 12 years and older with a FEV1 ≥35% predicted will be recruited.
Following baseline assessments (2 visits) patients will be randomized into an intervention
and a control group. Thereafter, they will be seen every 3 months for assessments in their
centre for one year (4 follow-up visits). Along with individual counseling to increase
vigorous physical activity by at least 3 hours per week on each clinic visit, the
intervention group will document daily exercise and inactivity time and will receive a step
counter and they will record their progress with a web-based program. They will also receive
monthly phone calls from the study staff. After 6 months, they will continue with the step
counter and web-based program for a further 6 months. The control group will receive access
to this intervention after 12 months of standardized care. Should this relatively simple
program prove successful, this will be made available on a wider scale internationally.


Inclusion Criteria:

- Confirmed diagnosis of Cystic Fibrosis

- Age ≥12 years

- Forced expiratory volume in 1 second (FEV1) ≥ 35% predicted

- Access to the internet

Exclusion Criteria:

- Participation in another clinical trial up to 4 weeks prior to the first baseline
visit

- Pregnancy/Breastfeeding

- Inability to exercise

- More than 4 hours of reported strenuous physical activities per week currently or up
to 3 months prior to baseline measurements and not already planned within the coming 6
months.

- Unstable condition precluding exercise (major hemoptysis or pneumothorax within the
last 3 months, acute exacerbation and iv-antibiotics during the last 4 weeks, planned
surgery, listed for lung transplantation, major musculoskeletal injuries such as
fractures or sprains during the last 2 months, others according to the impression of
the doctor)

- Cardiac arrhythmias with exercise

- Requiring additional oxygen with exercise

- Recent diagnosis of diabetes 3 months prior to screening or at screening

- Recent changes in medication 1 month or less prior to screening (systemic steroids,
ibuprofen, inhaled antibiotics, mannitol, DNAse, hypertonic saline)

- At least one G551D mutation and not on ivacaftor (VX770) yet but planned start or
planned stop of ivacaftor during the trial

- Colonization with Burkholderia cenocepacia
We found this trial at
3
sites
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
412-692-5325
Principal Investigator: David M. Orenstein, MD, MA
Phone: 412-692-5873
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Principal Investigator: John D Lowman, PT, PhD
Phone: 205-934-5892
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Graz,
Principal Investigator: Ernst Eber, Prof. Dr.
?
mi
from
Graz,
Click here to add this to my saved trials